In this recorded webinar, panelists provide a brief overview of Xylazine, a substance newly found in illicit drug supplies, and its impacts on the unsheltered community. Panelists will share their lived expertise with xylazine, its effects, organizational best practices for wound care, overdose response, and harm reduction.
This document provides information on xylazine, a non-opioid veterinary tranquilizer used as an additive in illicit drug supplies, notably in combination with heroin and fentanyl. It discusses the effects of xylazine use, including sedation and potential risks such as hypotension and bradycardia. The document also emphasizes harm reduction interventions for individuals who may encounter xylazine in the drug supply, including the use of naloxone for responding to overdoses and the importance of wound identification and treatment.
This poster identifies some of the most common harm reduction methods in an attempt to normalize the term “harm reduction” and broaden the definition.
This toolkit is a culturally responsive resource designed to help Native communities implement harm reduction strategies, decolonize public health approaches, reduce stigma, and engage Tribal leaders in supporting life-saving interventions.
A toolkit addressing faith and faith leadership in engaging with people who use drugs and harm reduction practices.
The SAMHSA Harm Reduction Framework is the first document to comprehensively outline harm reduction and its role within the Department of Health and Human Services (HHS). The Framework will inform SAMHSA’s harm reduction activities moving forward, as well as related policies, programs, and practices.